"A team led by Assistant Professor Minh Le of the Institute for Digital Medicine (WisDM) and Department of Pharmacology at the National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine) has demonstrated that extracellular vesicles (EVs) from human red blood cells could be repurposed to deliver anti-cancer drugs directly to lung cancer cells.
This innovative approach, in partnership with the Cancer Science Institute of Singapore (CSI Singapore), A*STAR, National Cancer Centre Singapore (NCCS), and Duke-NUS Medical School, leverages nano-sized EVs as carriers to deliver antisense oligonucleotide (ASO) molecules, which inhibit specific cancer cell activities."
Tested on lung cancer, but could be used to other forms of cancer...
Focal Therapy
Testosterone “Flare” (Or Testosterone?) Timing to Optimize Salvage Radiation Therapy